U.S. Markets open in 3 hrs 51 mins

Sera Prognostics, Inc. (SERA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.30-0.68 (-7.57%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close8.98
Open8.95
Bid0.00 x 800
Ask0.00 x 900
Day's Range8.29 - 9.57
52 Week Range7.81 - 15.50
Volume476,491
Avg. Volume178,947
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • GlobeNewswire

    Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer

    Dr. Michael R. Foley Sera Prognostics Appoints Dr. Michael R. Foley as Chief Medical Officer SALT LAKE CITY, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Dr. Michael R. Foley has been appointed to the position of Chief Medical Officer beginning in January 2022. Dr. Foley will lead all medical ac

  • GlobeNewswire

    Sera Prognostics Announces Publication of Health Economic Analysis Supporting PreTRM® Test-and-Treat Strategy to Improve Maternal and Infant Health

    Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs Positive impact on preterm births, neonatal intensive care admissions, overall hospital length of stay and a net $54 million reduction in total costs in the analyzed population SALT LAKE CITY, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™, focused on improving maternal and neonatal health by providing i

  • GlobeNewswire

    Sera Prognostics to Present at Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit

    SALT LAKE CITY, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company™ (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on Tuesday, September 21, 2021 at 8:15 a.m. Eastern Time. Gregory C. Critchfield, M.D., M.S., Chairman and CEO, will provide a company update a